Artiva Biotherapeutics Inc (ARTV)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
4.27 +0.23 (+5.69%) 03/21/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 4.27 unch (unch) 16:20 ET
for Fri, Mar 21st, 2025
Results
download Want to compare other data? Select Fields| Symbol | ARTV | AZN | AMGN | GILD | VRTX |
| Company | Artiva Biotherapeutics Inc | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 4.02 | 75.59 | 311.82 | 105.16 | 505.42 |
| High | 4.75 | 75.90 | 316.49 | 107.42 | 510.08 |
| Low | 3.64 | 74.68 | 311.16 | 104.92 | 501.07 |
| Last | 4.27 | 74.93 | 316.04 | 107.08 | 503.20 |
| Change | +0.23 | -1.59 | +1.00 | +1.21 | -6.98 |
| % Change | +5.69% | -2.08% | +0.32% | +1.14% | -1.37% |
| Volume | 662,700 | 5,173,000 | 9,995,000 | 26,497,500 | 2,280,500 |
| 20-Day Average Volume | 130,045 | 6,216,955 | 3,393,335 | 10,958,615 | 1,374,950 |
| Previous Close | 4.04 | 76.52 | 315.04 | 105.87 | 510.18 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 4.72 | 76.29 | 314.78 | 112.62 | 493.70 |
| 20-Day Raw Stochastic | 22.26% | 17.96% | 39.48% | 15.60% | 64.31% |
| 20-Day Relative Strength | 42.53% | 52.24% | 58.97% | 50.17% | 60.40% |
| Weighted Alpha | -70.80 | +9.93 | +13.53 | +53.98 | +21.28 |
| Today's Opinion | N/A | 40% Buy | 56% Buy | 80% Buy | 72% Buy |
| Previous Opinion | N/A | 56% Buy | 56% Buy | 80% Buy | 56% Buy |
| Last Month's Opinion | N/A | 8% Buy | 24% Sell | 100% Buy | 24% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -16.27% since 03/14/25 | -3.44% since 03/14/25 | +0.74% since 03/14/25 | -3.91% since 03/14/25 | -0.31% since 03/14/25 |
| Low | 3.64 on 03/21/25 | 74.68 on 03/21/25 | 311.16 on 03/21/25 | 104.70 on 03/20/25 | 501.07 on 03/21/25 |
| High | 5.98 on 03/17/25 | 77.76 on 03/17/25 | 319.31 on 03/18/25 | 112.56 on 03/17/25 | 517.20 on 03/17/25 |
| 1-Month | |||||
| %Chg | +13.26% since 02/21/25 | +0.96% since 02/21/25 | +4.30% since 02/21/25 | -2.61% since 02/21/25 | +3.92% since 02/21/25 |
| Low | 3.62 on 02/28/25 | 74.18 on 03/11/25 | 303.10 on 02/27/25 | 104.70 on 03/20/25 | 473.51 on 02/27/25 |
| High | 6.54 on 03/12/25 | 78.36 on 03/05/25 | 335.88 on 03/10/25 | 119.96 on 03/10/25 | 519.68 on 03/14/25 |
| 3-Month | |||||
| %Chg | -61.57% since 12/20/24 | +14.66% since 12/20/24 | +19.99% since 12/20/24 | +15.67% since 12/20/24 | +26.66% since 12/20/24 |
| Low | 3.37 on 02/12/25 | 64.22 on 01/14/25 | 257.05 on 01/06/25 | 88.57 on 01/10/25 | 390.92 on 12/23/24 |
| High | 11.55 on 01/08/25 | 78.36 on 03/05/25 | 335.88 on 03/10/25 | 119.96 on 03/10/25 | 519.68 on 03/14/25 |
| 6-Month | |||||
| %Chg | -65.73% since 09/20/24 | -4.40% since 09/20/24 | -6.33% since 09/20/24 | +27.57% since 09/20/24 | +8.23% since 09/20/24 |
| Low | 3.37 on 02/12/25 | 62.75 on 11/18/24 | 253.30 on 12/19/24 | 81.83 on 09/26/24 | 377.85 on 12/19/24 |
| High | 17.31 on 10/01/24 | 79.76 on 10/02/24 | 339.17 on 09/23/24 | 119.96 on 03/10/25 | 519.88 on 11/08/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 103,714 | 232,373,984 | 169,778,272 | 133,351,648 | 129,216,736 |
| Shares Outstanding, K | 24,289 | 3,101,214 | 537,205 | 1,245,346 | 256,790 |
| Annual Sales | 33,492,000 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -27,696,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 0 | 14,891,000,000 | 9,086,000,000 | 7,569,000,000 | 2,912,000,000 |
| Last Quarter Net Income | -17,840,000 | 1,499,000,000 | 627,000,000 | 1,783,000,000 | 913,000,000 |
| 60-Month Beta | N/A | 0.41 | 0.53 | 0.21 | 0.41 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.92 on 11/12/24 | 1.05 on 02/06/25 | 5.31 on 02/04/25 | 1.90 on 02/11/25 | 3.98 on 02/10/25 |
| Latest Earnings Date | 03/25/25 | 04/24/25 | 05/01/25 | 04/24/25 | 05/05/25 |
| Most Recent Dividend | N/A | 1.030 on 02/21/25 | 2.380 on 02/14/25 | 0.790 on 03/14/25 | N/A |
| Next Ex-Dividends Date | N/A | 02/21/25 | 05/16/25 | 03/14/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 18.62 | 15.90 | 22.97 | 0.00 |